In recent years, the global landscape of weight management has been transformed by medications like Ozempic (semaglutide), a GLP-1 receptor agonist primarily used to treat type 2 diabetes and aid in weight loss. However, in India, Ozempic has not been officially launched, leading healthcare providers and patients to explore alternative options.
Ozempic comes with certain challenges that may make it less suitable for some individuals.
One of the primary concerns is its high cost, making it an expensive option that is not easily affordable for all patients.
Additionally, availability issues can arise, as it may not be widely stocked in all pharmacies, limiting access for those who need it.
Another factor to consider is the potential side effects, with some individuals experiencing nausea, vomiting, and gastrointestinal discomfort.
Lastly, treatment preferences vary, and some patients may opt for oral medications or non-medication-based approaches, such as lifestyle changes and diet modifications, instead of injectable treatments like Ozempic.
Medical Alternatives to Ozempic
1. Mounjaro (Tirzepatide)
Newly launched in India (March 2025).
Dual GIP/GLP-1 receptor agonist, offering better blood sugar control and weight loss than Ozempic.
Dosage: Weekly injection (2.5 mg to 15 mg).
Pros: Superior weight loss and glucose control.
Cons: High cost, injection-based therapy.
2. Rybelsus (Oral Semaglutide)
Same active ingredient as Ozempic but available in an oral form.
Dosage: Daily tablet (3 mg, 7 mg, or 14 mg).
Pros: Convenient oral option, no injection required.
Cons: Must be taken on an empty stomach, slightly less effective than injectable forms.
3. Trulicity (Dulaglutide)
Once-weekly injection similar to Ozempic.
Dosage: 0.75 mg to 4.5 mg weekly.
Pros: Effective for blood sugar control and weight loss.
Cons: Injection required, cost can be high.
4. Victoza (Liraglutide)
Daily injectable GLP-1 receptor agonist.
Dosage: 0.6 mg to 1.8 mg daily.
Pros: Works similarly to Ozempic.
Cons: Requires daily injections, lower weight loss benefits.
5. DPP-4 Inhibitors (Non-GLP-1 Alternatives)
For those who cannot tolerate GLP-1 receptor agonists, DPP-4 inhibitors offer a more affordable option:
Sitagliptin (Januvia, Istavel, Zita-Met)
Vildagliptin (Galvus, Jalra)
Teneligliptin (Tenelia, Tenglyn)
For weight loss solutions Elevate Now is one of the leading platforms where doctors assess eligibility, identify underlying factors, and guide you with medically supervised GLP-1 alternatives.
Elevate Now stands out by combining advanced medical science with personalized care for effective, sustainable results. As India's only legally approved GLP-1 provider, it ensures safe access to Semaglutide and Liraglutide under expert medical supervision.
Why Choose Elevate Now?
Comprehensive Diagnosis – The EN.Insight Diagnostic Plan helps identify metabolic conditions affecting weight loss, including an 85-parameter blood test and expert consultations.
Doctor-Led GLP-1 Weight Loss Programs – Elevate Now provides pharmacotherapy-based plans, including GLP-1 medications and other doctor-prescribed treatments tailored for Indian metabolic health and diet. (Check your eligibility here).
Proven Success – Trusted by 3,000+ users, with medically guided weight loss solutions that combine safe medications with nutrition, fitness, and habit coaching for sustainable results.
Guaranteed Weight Loss Plan – A premium subscription plan ensuring 10% weight loss within six months or a refund. Includes CGM devices, diagnostics, and expert consultations to track progress effectively.
Affordable & Accessible – Pricing starts at Rs 1,799 for diagnostics, Rs 9,999 for weight loss plans, and Rs 21,999 for guaranteed results, with potential insurance coverage for the Allurion Gastric Balloon.
Patients who are looking for scientifically-backed, structured treatment for weight management and diabetes control can explore Elevate Now under the guidance of experienced medical professionals. (Check your eligibility here).
To Conclude,
Patients in India looking for Ozempic alternatives have multiple options, including Mounjaro, Rybelsus, Trulicity, Victoza, and DPP-4 inhibitors. Additionally, ElevateNow provides a non-medical, lifestyle-based alternative for those looking to improve their health naturally. The best option depends on budget, medical needs, and personal preference. Consulting a healthcare provider is essential for making the right choice.
